(2022) 40:700-708 preclinical studies the radiosensitizing effect of β-thujaplicin tropolone derivative inducing s-phase cell cycle arrest in head and neck squamous cell carcinoma-derived cell lines

HIGHLIGHTS

• who: Investigational New Drugs ( and collaborators from the Department of Otorhinolaryngology, Medical University of Vienna, Wu00e4hringer Gu00fcrtel, Vienna, Austria have published the research: (2022) 40:700-708 PRECLINICAL STUDIES The radiosensitizing effect of u03b2-Thujaplicin tropolone derivative inducing S-phase cell cycle arrest in head and neck squamous cell carcinoma-derived cell lines, in the Journal: (JOURNAL)
• what: The authors aimed to investigate the potential radiosensitizing effect of u00df-Thujaplicin in two HNSCC cell lines and its effects on cell viability, clonogenic survival, cell cycle and migration. Next, the authors aimed to determine baseline radiosensitivity . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.